Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M33.3Revenue (TTM) $M5.3Net Margin (%)11.3Altman Z-Score4.8
Enterprise Value $M33.5EPS (TTM) $0.0Operating Margin %12.6Piotroski F-Score3
P/E(ttm)52.0Beneish M-Score1.2Pre-tax Margin (%)11.3Higher ROA y-yY
Price/Book6.810-y EBITDA Growth Rate %--Quick Ratio2.6Cash flow > EarningsN
Price/Sales6.55-y EBITDA Growth Rate %--Current Ratio2.6Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)8.5Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)12.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M63.6ROIC % (ttm)21.3Gross Margin Increase y-yN

Gurus Latest Trades with IGXT

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

IGXT is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


IGXT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Boudreau BernardDirector 2016-01-22Buy65,000$0.496.12view
Bechard Robert J.VP Corporate Development 2016-01-22Buy10,000$0.54view
Godin AndreEVP + CFO 2016-01-20Buy20,000$0.430view
Godin AndreEVP & CFO 2015-12-30Buy9,500$0.520view
Godin AndreEVP + CFO 2015-12-23Buy15,350$0.511.96view
Godin AndreEVP + CFO 2015-12-22Buy19,650$0.54view
Zerbe IngridCorporate Secretary 2015-08-25Sell163,100$0.54view
Zerbe Horst GCEO 2015-08-25Sell36,900$0.54view
Zerbe IngridCorporate Secretary 2015-04-20Sell66,900$0.66-21.21view
Zerbe Horst GCEO 2015-04-17Sell60,000$0.66-21.21view

Press Releases about IGXT :

Quarterly/Annual Reports about IGXT:

News about IGXT:

Articles On GuruFocus.com
No related article found.

More From Other Websites
IntelGenx to Initiate Phase 1 Trial of Montelukast Jul 13 2016
INTELGENX TECHNOLOGIES CORP. Files SEC form 8-K, Other Events Jul 13 2016
IntelGenx to Initiate Phase 1 Trial of Montelukast Jul 13 2016
IntelGenx Announces Notice of Appeal for Buprenorphine/Naloxone Sublingual Film Product for the... Jul 11 2016
INTELGENX TECHNOLOGIES CORP. Files SEC form 8-K, Other Events Jul 11 2016
IntelGenx Announces Notice of Appeal for Buprenorphine/Naloxone Sublingual Film Product for the... Jul 11 2016
IntelGenx and RedHill Biopharma Announce Signing of Definitive Agreement for Commercialization of... Jul 05 2016
INTELGENX TECHNOLOGIES CORP. Files SEC form 8-K, Other Events Jul 05 2016
RedHill Biopharma and IntelGenx Announce Definitive Agreement for Commercialization of RIZAPORT™... Jul 05 2016
IntelGenx and RedHill Biopharma Announce Signing of Definitive Agreement for Commercialization of... Jul 05 2016
IntelGenx Technologies Corp. :IGXT-US: Earnings Analysis: Q1, 2016 By the Numbers : June 24, 2016 Jun 24 2016
INTELGENX TECHNOLOGIES CORP. Financials May 19 2016
IntelGenx Reports Amendment of Stock Option Plan May 12 2016
INTELGENX TECHNOLOGIES CORP. Files SEC form 8-K, Other Events May 12 2016
IntelGenx Reports Amendment of Stock Option Plan May 12 2016
INTELGENX TECHNOLOGIES CORP. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 11 2016
IntelGenx reports 1Q loss May 10 2016
IntelGenx reports 1Q loss May 10 2016
IntelGenx Reports First Quarter 2016 Financial Results May 10 2016
INTELGENX TECHNOLOGIES CORP. Files SEC form 10-Q, Quarterly Report May 10 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)